IINN VS VAPO Stock Comparison

PerformanceSentimentTechnicalsEarningsProfitVolatilityAnalyst Price Targets
PerformanceSentimentTechnicalsEarningsProfitVolatilityAnalyst Price Targets

Performance

IINN
10/100

IINN returned -8.60% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

VAPO
10/100

VAPO returned -41.43% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Sentiment

IINN
64/100

IINN had a bullish sentiment score of 63.94% across Twitter and StockTwits over the last 12 months. It had an average of 2.16 posts, 0.42 comments, and 2.10 likes per day.

VAPO
73/100

VAPO had a bullish sentiment score of 73.42% across Twitter and StockTwits over the last 12 months. It had an average of 2.12 posts, 0.00 comments, and 0.00 likes per day.

Technicals

IINN
10/100

IINN receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.

VAPO
43/100

VAPO receives a 42 of 100 based on 14 indicators. 5 are bullish, 7 are bearish.

Earnings

IINN
100/100

IINN has missed earnings 0 times in the last 20 quarters.

VAPO
10/100

VAPO has missed earnings 9 times in the last 20 quarters.

Profit

IINN
21/100

Out of the last 18 quarters, IINN has had 3 profitable quarters and has increased their profits year over year on 3 of them.

VAPO
10/100

Out of the last 20 quarters, VAPO has had 0 profitable quarters and has increased their profits year over year on 0 of them.

Volatility

IINN
40/100

IINN has had a lower than average amount of volatility over the last 12 months giving it a score of 40 of 100.

VAPO
44/100

VAPO has had a lower than average amount of volatility over the last 12 months giving it a score of 43 of 100.

Analyst Price Targets

IINN

"Analyst Price Targets" not found for IINN

VAPO
100/100

4 analysts offer 12-month price targets for VAPO. Together, they have an average target of 128, the most optimistic target put VAPO at 128 within 12-months and the most pessimistic has VAPO at 128.

All score calculations are broken down here to help you make more informed investing decisions

Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares Summary

Nasdaq / IINN
Healthcare
Medical - Devices
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

Vapotherm, Inc. Common Stock Summary

New York Stock Exchange / VAPO
Healthcare
Medical Devices
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.